Published 2002 by NABC.

The promise of biotechnology, especially as it relates to food, is about shared responsibility and trust. Merging healthful eating with medicines in our foods is part of the promise of biotechnology and food-based products that may have medicinal capacity. Biotechnology and agriculture also offer new ways to make vaccines, more cheaply, more effectively, and with greater capacity, actually growing medicines, or “pharming.” Agriculture and health have always been linked, and a new relationship is evolving requiring interdisciplinary approaches and new thinking. There is also the need to share responsibility for safety and for the accountability of the progresses. Promises regarding agricultural biotechnology must be realistic and objective and must be evaluated with an eye to political and moral and must be kept throughout the whole chain from producers to consumers.

How do we assure that the public understands what the risks and benefits? We cannot assure them until we ourselves understand the risks to human health, especially that of our children, and to the environment. Until we do, we must at least provide objective and creditable information. We have to educate people keeping in mind cultural aspect to food. Rituals and traditions are not to be trifled with when we talk about genetically modifying food.

If the consumers of genetically modified foods don’t trust it, they won’t buy it no matter what health claims are made and even delivered. Trust in the regulatory agencies is generally strong where medicines are concerned, but not so much for genetically modified foods. Only transparency can help, even if it means to address problems such as the Starlink™ corn. Producers must be sure that they can sell their products and they must be trusted by the public that the food they produce is safe.

Recent Submissions

  • How to approach the regulatory conundrum? 

    Jaffe, Gregory (NABC, 2002)
    There is a need for a stronger regulatory system to ensure food safety and to promote public acceptance of GM food. The great promise—more-nutritious foods, better pharmaceuticals, and plants producing antibodies and edible ...
  • Our Healthy Future: the global context 

    McGovern, George (NABC, 2002)
    The World Food Summit’s resolution is to halve the number of chronically hungry people in the world—from 800 million to 400 million—by 2015. The United Nations, with the United States in the lead, need commit to providing ...
  • Targeted nutrition in health and disease 

    Johnson, Clarence (NABC, 2002)
    The Dietary Supplement Health and Education Act of 1994 created a new, and sometimes controversial, industry based on diet and health. Functional foods and nutraceuticals are foods or ingredients that are perceived by the ...
  • Consumer impact on nutritional products 

    Snyder, Steve; Rosenberg, Roberta (NABC, 2002)
    Industry will continue to play a valuable role in developing healthy, effective, and safe ingredients, and in making new functional foods available to the consumer. These contributions fall into four major categories: ...
  • The food industry: Promoting public health 

    Crockett, Susan (NABC, 2002)
    The food industry provides a key link between agriculture and health, and is an important contributor to public health. Direct and indirect communications are necessary in order to reach consumers with public-health ...
  • Q&A : The Food Industry: Promoting Public Health 

    Muscoplat, Charles C (NABC, 2002)
    Q&A: Developments in safe and healthy foods
  • The Center for Plants and Human Health: An interdisciplinary approach 

    Gardner, Gary (NABC, 2002)
    The current model for competitive research funding in the United States is primarily single-principal-investigator grants in a single discipline, but new approaches to the relationships between plants and human health will ...
  • Integrative medicine: Agriculture’s new opportunity 

    Plotnikoff, Gregory A. (NABC, 2002)
    In regard to the public’s health, agriculture and the prepared-food industry have both a significant responsibility and a significant opportunity. New partnerships must be developed to identify the best business- and best ...
  • Q&A : Luncheon Addresses 

    Cerra, Frank (NABC, 2002)
    Q&A: Developments in medicine and health
  • Genomics education at the Mayo Clinic: A new model for data and information 

    Bolander, Mark (NABC, 2002)
    The Mayo Clinic is engaged in an aggressive effort to prepare the staff and the allied healthcare for changes in medicine, with genomics and medical genomics becoming a central part of the therapies that we will offer. The ...

View more


RSS Feeds